Melanie Sena is community editor of Pharmaceutical Technology.
Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.
CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.
Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.
Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.
FDA approves the orphan drug Myalept for the treatment of leptin deficiency.
Novartis provides its second US university with Bexsero for the treatment of meningitis B.
Elanco acquires Germany-based Lohmann Animal Health.
Ben Venue issues a voluntary patient level recall of Acetylcysteine Solution 10% due to glass particle in vial.
Debiopharm acquires Affinium's clinical and preclinical assets and its technology platform.